neuroblastoma
nb
common
cancer
first
year
life
common
solid
tumor
childhood
patient
riskstratifi
use
combin
clinic
patholog
molecular
characterist
surviv
patient
highrisk
diseas
improv
remain
less
histor
standard
therapi
highrisk
diseas
includ
chemotherapi
surgeri
radiat
bone
marrow
transplant
appear
provid
control
diseas
progress
complic
signific
morbid
innov
approach
antibodymedi
immun
therapi
demonstr
first
improv
surviv
highrisk
nb
patient
two
decad
though
mechan
limit
efficaci
still
therefor
novel
approach
diseas
necessari
viral
oncolysi
novel
approach
nb
shown
promis
variou
preclin
cancer
despit
promis
therapeut
oncolyt
virus
ov
face
applic
hurdl
due
incomplet
understand
role
tumor
microenviro
antivir
immun
respons
virotherapi
gener
ov
select
kill
tumor
cell
leav
normal
cell
achiev
exploit
cellular
defect
promot
tumor
growth
one
defect
type
interferon
ifn
signal
sensit
tumor
cell
ifnsensit
ov
vesicular
stomat
viru
vsv
newcastl
diseas
studi
use
vsv
base
known
efficaci
potent
oncolyt
agent
sever
tumor
delet
singl
amino
acid
mprotein
increas
safeti
restrict
infect
cancer
cell
defect
type
ifn
howev
tumor
function
type
ifn
signal
hamper
clinic
nmyc
amplif
although
present
bestcharacter
aberr
genet
alter
associ
poor
prognosi
highrisk
mechan
wherebi
myc
protein
cmyc
nmyc
lmyc
sensit
cancer
cell
ov
remain
unexplor
previou
studi
shown
cmycamplifi
cancer
cell
line
highli
suscept
vsvinduc
cell
though
studi
context
oncolyt
virotherapi
cmyc
neg
regul
type
ifn
signal
one
mechan
pathogenesi
burkitt
lymphoma
uveal
sinc
oncogen
express
often
correl
increas
suscept
cancer
cell
effect
nmyc
virotherapi
unknown
reason
nmyc
overexpress
due
amplif
could
clinic
import
biomark
virotherapi
efficaci
highrisk
nb
show
nmycamplifi
nb
cell
line
nonnmycamplifi
cell
line
induc
overexpress
exogen
nmyc
augment
suscept
virusinduc
cell
kill
fail
establish
robust
type
ifnstimul
antivir
state
studi
effect
nmyc
suscept
ov
perform
microarray
analysi
cell
express
low
high
level
exogen
nmyc
infect
found
sever
interferonstimul
gene
isg
antivir
function
downregul
nmyc
level
increas
furthermor
chang
global
gene
express
upon
infect
nearli
higher
high
nmyc
respect
low
nmyc
sinc
oncogen
express
statu
often
determin
virotherapi
respons
shown
preclin
hypothes
nmyc
overexpress
consequ
amplif
would
sensit
nb
cell
ov
test
hypothesi
first
use
humanderiv
highrisk
nb
cell
line
consist
nmycamplifi
neuroblast
n
cell
non
nmycamplifi
substrateadher
cell
sknh
skna
shep
previou
studi
shown
nmyc
express
statu
correl
n
cell
infect
multipl
infect
moi
studi
product
infect
viru
spread
product
infect
differ
viru
spread
vari
among
analyz
cell
line
appar
correl
nmyc
amplificationoverexpress
statu
figur
next
examin
oncolyt
effect
cell
line
interestingli
virusinduc
cell
kill
kinet
faster
nmycamplifi
cell
non
nmycamplifi
cell
figur
nb
cell
line
well
known
differ
genet
phenotyp
biochem
tumorigen
sinc
effect
nmyc
viru
replic
may
obscur
celltyp
specif
differ
use
isogen
cell
system
allow
exquisit
regul
nmyc
tetracyclin
cell
deriv
nonnmyc
amplifi
shep
cell
line
express
nearli
undetect
level
nmyc
presenc
doxycyclin
low
nmyc
withdraw
antibiot
induc
overexpress
high
nmyc
rule
effect
doxycyclin
use
control
cell
isogen
cell
without
exogen
nmyc
express
nmyc
cell
either
untreat
treat
doxycyclin
dox
monitor
rtpcr
western
blot
assay
viru
spread
shown
multistep
growth
curv
moi
slightli
faster
high
nmyc
although
viru
titer
differ
significantli
observ
low
nmyc
p
figur
cell
dox
show
signific
differ
viru
spread
figur
viru
replic
determin
onestep
growth
curv
moi
slightli
higher
high
nmyc
signific
differ
viru
titer
observ
low
nmyc
p
supplementari
figur
cell
dox
equal
support
viru
replic
supplementari
figur
therefor
observ
collect
suggest
nmyc
affect
rate
viru
replic
spread
nb
cell
consist
observ
nb
cell
line
high
nmyc
significantli
faster
cell
kill
kinet
low
nmyc
p
figur
cell
kill
kinet
chang
dox
figur
data
suggest
nmyc
express
sensit
nb
cell
virusinduc
cell
kill
sinc
vsv
infect
induc
express
type
hypothes
nmycdriven
regul
cytokin
promot
differenti
suscept
nb
cell
virusinduc
cell
kill
posit
control
assay
cell
treat
polyinosinicpolycytidyl
acid
poli
c
hour
poli
c
strong
induc
type
ifn
deliv
intracellularli
transfect
extracellularli
cell
cultur
medium
intracellular
extracellular
poli
c
mainli
activ
retino
acidinduc
gene
rigi
tolllik
signal
respect
express
type
cell
either
infect
moi
treat
poli
c
intracellular
extracellular
cell
cell
cultur
supernat
harvest
indic
time
point
secret
detect
quantifi
elisa
rtpcr
use
detect
transcript
detect
quantit
secret
perform
hpi
cytokin
best
detect
hpi
thu
analysi
focus
time
point
figur
level
increas
cell
respons
infect
except
dox
howev
increas
level
cytokin
differ
significantli
basal
level
p
except
surprisingli
dox
level
increas
upon
stimul
poli
c
either
intracellular
extracellular
figur
interestingli
increas
level
cytokin
high
nmyc
significantli
differ
basal
level
p
contrast
endogen
level
significantli
increas
low
nmyc
dox
upon
poli
c
treatment
p
level
virusinfect
poli
ctreat
high
nmyc
differ
significantli
p
contrast
level
cytokin
poli
ctreat
low
nmyc
dox
significantli
higher
level
observ
virusinfect
cell
p
observ
collect
suggest
regardless
nmyc
express
statu
viru
infect
seem
induc
enough
level
stimul
antivir
state
cell
nmyc
seem
neg
effect
express
cytokin
stimul
poli
c
transcript
level
signific
increas
observ
upon
infect
intracellular
poli
c
interestingli
transcript
level
lower
high
nmyc
low
nmyc
supplementari
figur
transcript
detect
upon
infect
stimul
extracellular
poli
c
high
low
nmyc
cell
dox
transcript
type
ifn
also
detect
nb
cell
upon
infect
treatment
poli
c
level
celltyp
specif
regardless
nmyc
amplif
statu
supplementari
figur
secret
viru
infect
poli
ctreat
cell
interact
ifn
receptor
activ
jakstat
pathway
activ
pathway
result
phosphoryl
tyrosin
allow
heterodimer
transloc
nucleu
associ
form
complex
activ
promot
express
sever
ifnstimul
gene
isg
collect
contribut
isg
render
cell
antivir
therefor
studi
ifn
signal
jakstat
analyz
express
complex
activ
stat
phosphoryl
analyz
express
rigi
readout
induct
jakstat
signal
cell
infect
moi
harvest
indic
time
point
cytopath
effect
appar
compon
complex
analyz
western
blot
control
assay
cell
treat
exogen
uml
extracellular
poli
c
intracellular
poli
c
includ
analysi
due
poor
induct
jakstat
signal
cell
base
rigi
express
supplementari
figur
basal
level
stat
phosphoryl
form
infect
similar
high
nmyc
low
nmyc
level
hand
slightli
lower
high
nmyc
figur
viru
infect
cell
induc
signific
chang
level
member
level
slightli
increas
upon
infect
low
high
nmyc
hpi
howev
hpi
level
slightli
increas
decreas
high
nmyc
low
nmyc
respect
observ
suggest
induc
robust
chang
jakstat
signal
cell
probabl
due
insuffici
level
express
treatment
extracellular
poli
c
upregul
express
rigi
significantli
increas
level
cell
regardless
nmyc
express
statu
figur
furthermor
level
protein
similar
cell
low
high
nmyc
rel
low
nmyc
dox
rigi
level
slightli
lower
high
nmyc
treatment
poli
c
figur
observ
suggest
jakstat
signal
function
regardless
nmyc
express
statu
consist
observ
cell
viru
infect
caus
signific
chang
express
stat
phosphoryl
form
analyz
nb
cell
figur
level
slightli
increas
nmycamplifi
shep
nonnmycamplifi
respons
infect
treatment
cell
upregul
express
member
rigi
though
express
phosphoryl
statu
stat
vari
among
cell
figur
consist
observ
system
upregul
isg
suggest
function
jakstat
signal
regardless
cell
type
nmyc
amplificationoverexpress
statu
sinc
jakstat
signal
function
cell
hypothes
treatment
prior
viru
infect
would
induc
antivir
state
nb
cell
cell
either
treat
poli
c
uml
hour
respect
follow
viru
infect
moi
indic
time
point
expect
infect
control
cell
result
cell
death
interestingli
treatment
high
nmyc
exogen
induc
weak
antivir
state
insuffici
protect
cell
virusinduc
cell
kill
cours
experi
figur
contrast
low
nmyc
dox
establish
robust
antivir
state
fulli
protect
cell
virusinduc
cell
kill
figur
b
similar
effect
antivir
state
cell
observ
treat
poli
c
figur
consist
observ
cell
system
nmycamplifi
cell
line
fail
establish
antivir
state
treat
poli
c
oppos
nmyc
amplif
figur
f
data
collect
suggest
nmycdepend
allevi
ifninduc
antivir
state
investig
neg
effect
nmyc
express
establish
antivir
state
studi
antivir
activ
condit
media
poli
ctreat
cell
also
includ
condit
media
cell
infect
hpi
uv
treat
minut
inactiv
viru
skna
cell
nonnmycamplifi
use
indic
due
abil
establish
robust
antivir
state
demonstr
work
sinc
extracellular
poli
c
activ
jakstat
signal
effici
intracellular
poli
c
supplementari
figur
cell
incub
dulbecco
modifi
eagl
medium
dmem
reduc
serum
without
poli
c
hour
remov
media
cell
wash
four
time
serumfre
medium
elimin
residu
poli
c
cell
incub
fresh
dmem
medium
without
serum
anoth
hour
cell
cultur
supernat
harvest
centrifug
fetal
bovin
serum
fb
ad
final
concentr
altern
cell
cultur
supernat
fourfold
concentr
fb
ad
concentr
nonconcentr
supernat
poli
c
virusinfect
cell
use
condit
media
skna
cell
incub
either
condit
media
regular
medium
fb
hour
follow
infect
moi
anoth
hour
nonconcentr
condit
media
control
virusinfect
poli
ctreat
cell
protect
skna
virusinduc
cell
kill
shown
treatment
skna
concentr
condit
media
poli
ctreat
low
nmyc
dox
establish
robust
antivir
state
supplementari
figur
b
interestingli
concentr
condit
media
poli
ctreat
high
nmyc
protect
skna
virusinduc
cell
kill
supplementari
figur
condit
media
infect
cell
protect
skna
virusinduc
cell
kill
shown
therefor
find
support
neg
role
nmyc
establish
antivir
state
sinc
nmyc
level
correl
differenti
suscept
virusinduc
cell
kill
sought
perform
microarray
assay
cell
studi
nmycdriven
global
chang
gene
express
respons
infect
assay
use
monitor
viru
infect
base
gfp
express
upon
optim
found
infect
moi
hour
suitabl
microarray
analysi
follow
reason
earlier
later
time
point
show
limit
infect
low
nmyc
extens
cytopath
effect
high
nmyc
respect
ii
infect
base
gfp
express
reach
cell
limit
cytopath
effect
high
nmyc
shown
iii
infect
rna
virus
high
moi
known
interfer
microarray
comparison
made
follow
group
low
nmyc
infecteduninfect
group
high
nmyc
infecteduninfect
group
control
high
nmyclow
nmyc
figur
illustr
comparison
group
number
identifi
probe
set
number
black
total
probe
set
identifi
low
nmyc
high
nmyc
respect
respons
infect
data
suggest
higher
number
chang
high
nmyc
respons
infect
seem
correl
increas
suscept
virusinduc
cell
kill
identifi
probe
set
correspond
isg
identifi
interferom
databas
sever
isg
known
antivir
function
induc
ifndepend
independ
mechan
respons
viru
therefor
focus
analysi
gene
total
probe
set
isg
identifi
exclus
group
respect
isg
common
group
respect
interestingli
identifi
isg
group
downregul
figur
total
isg
downregul
nmyc
overexpress
figur
gene
known
antivir
function
tabl
shown
figur
basal
slightli
lower
high
nmyc
low
nmyc
consist
microarray
data
isg
neg
regul
ifn
signal
potenti
provir
function
also
found
downregul
nmi
tabl
observ
suggest
nmycdriven
downregul
isg
antivir
function
may
sensit
cell
virusinduc
cell
kill
contribut
allevi
ifninduc
antivir
state
infect
cell
downregul
express
gene
respect
regardless
nmyc
express
statu
figur
tabl
fold
chang
transcript
gene
slightli
higher
high
nmyc
except
interestingli
transcript
also
known
highest
fold
chang
respons
infect
high
nmyc
low
nmyc
respect
though
role
viru
replic
unclear
shown
revers
prolif
signal
polyomaviru
middl
tantigen
transform
rat
current
investig
role
vsv
replic
oncolysi
eight
probe
set
isg
exclus
identifi
low
nmyc
respons
infect
figur
tabl
though
pro
antivir
function
isg
report
contribut
vsv
infect
unknown
infect
high
nmyc
caus
chang
express
probe
set
isg
figur
tabl
supplementari
tabl
probe
set
downregul
respect
identifi
isg
unknown
role
viru
replic
tabl
list
identifi
isg
known
pro
antivir
function
upregul
isg
antivir
function
includ
mafg
trim
downregul
isg
antivir
function
includ
tank
probe
set
highli
upregul
isg
respons
infect
suggest
possibl
implic
differenti
suscept
determin
nmyc
known
pro
antivir
transcript
factor
upregul
cellular
stress
includ
glucos
depriv
amino
acid
starvat
endoplasm
reticulum
er
stress
viru
direct
role
vsv
replic
yet
determin
valid
find
cell
infect
moi
hour
control
express
cell
either
treat
tunicamycin
er
poison
hour
upon
viru
infect
protein
detect
hpi
high
nmyc
undetect
low
nmyc
dox
tunicamycin
treatment
robustli
induc
cell
regardless
nmyc
express
statu
figur
valid
find
analyz
nb
cell
line
protein
level
could
detect
despit
sever
attempt
transcript
level
respons
infect
vari
among
analyz
nb
cell
regardless
nmyc
express
statu
figur
exampl
slight
upregul
observ
nmycamplifi
skna
nonnmycamplifi
chang
observ
nmycamplifi
shep
nonnmycamplifi
find
suggest
link
nmyc
may
restrict
cell
system
perhap
certain
nb
cell
popul
oncolyt
virus
ov
promis
new
therapi
mani
cancer
type
includ
highrisk
howev
applic
clinic
could
hamper
due
complex
tumor
microenviro
presenc
host
immun
respons
ov
understood
interact
cancer
cell
stroma
contribut
cancer
progress
metastasi
resist
chemo
drug
recurr
resist
due
highli
heterogen
natur
nb
surpris
subpopul
tumor
cell
differ
permiss
viru
infect
function
ifn
signal
would
hamper
virotherapi
efficaci
perform
vitro
assay
studi
nmyc
express
viru
suscept
innat
immun
context
virotherapi
nb
studi
use
cell
power
system
studi
nmyc
nb
cell
system
allow
overexpress
nmyc
ad
remov
tetracyclin
cell
cultur
medium
tetoff
system
howev
limit
system
includ
use
tetracyclin
known
alter
cellular
gene
express
thu
confound
microarray
lack
tumorigen
capac
low
nmyc
perform
vivo
studi
tetracyclin
seem
major
effect
express
dox
respons
infect
though
express
cytokin
poli
c
treatment
viru
replic
virusinduc
cell
kill
establish
antivir
state
seem
affect
antibiot
furthermor
skna
cell
protect
condit
media
infect
dox
cell
shown
suggest
limit
effect
doxycyclin
virusinduc
cell
kill
although
cautiou
interpret
data
tetsystem
paramount
mani
microarray
hit
cell
arrayepress
access
number
valid
hit
wnt
signal
pathway
consist
microarray
data
although
includ
microarray
analysi
effect
tetracyclin
could
rule
valid
hit
cmyc
semiquantit
rtpcr
confirm
microarray
analysi
shown
littl
known
role
myc
oncoprotein
famili
suscept
cancer
cell
ov
cell
line
transform
cmyc
suscept
vsv
role
promot
virusinduc
oncolysi
transform
cell
remain
unknown
studi
found
nmyc
caus
signific
chang
level
viru
replic
either
analyz
nb
cell
howev
nmycamplifi
cell
high
nmyc
increas
suscept
virusinduc
cell
kill
fail
establish
robust
antivir
state
induc
exogen
ifn
poli
c
either
extracellular
intracellular
viru
infect
caus
seriou
chang
jakstat
signal
probabl
due
insuffici
level
secret
treatment
exogen
poli
c
hand
caus
signific
chang
express
phosphoryl
level
protein
regardless
nmyc
express
statu
overal
western
blot
microarray
data
suggest
nmyc
overexpress
affect
ifn
signal
jakstat
pathway
directli
rather
express
isg
stimul
pathway
therefor
find
suggest
increas
suscept
nb
cell
allevi
type
ifninduc
antivir
state
nmyc
least
involv
downregul
isg
antivir
function
find
contrast
previou
studi
show
neg
effect
cmyc
ifn
signal
jakstat
pathway
context
pathogenesi
burkitt
lymphoma
uveal
studi
demonstr
protein
member
ifn
signal
downregul
cmyc
dosedepend
western
blot
analys
hand
show
drastic
differ
level
protein
activ
jakstat
signal
phosphoryl
stat
nmyc
overexpress
figur
observ
elev
level
cmyc
nonnmycamplifi
nb
cell
express
significantli
decreas
nmyc
overexpress
shown
despit
elev
cmyc
level
cell
treatment
poli
c
establish
robust
antivir
state
therefor
observ
previous
report
suggest
differenti
function
myc
protein
ifn
signal
perhap
suscept
viru
infect
establish
antivir
state
rel
low
nmyc
signific
chang
global
gene
express
observ
high
nmyc
though
one
time
point
examin
hpi
differenti
chang
global
gene
express
driven
nmyc
like
occur
whole
replic
cycl
viru
spread
identifi
isg
unknown
antivir
function
highli
like
collect
contribut
isg
nonisg
sensit
cell
viru
infect
allevi
ifnstimul
antivir
state
interestingli
known
proapoptot
function
highli
upregul
isg
high
nmyc
respons
infect
find
confirm
western
blot
suggest
possibl
link
nmyc
howev
express
respons
infect
cell
linedepend
regardless
nmyc
express
statu
sinc
nb
highli
heterogen
malign
would
surpris
link
restrict
cell
system
perhap
nb
cell
popul
seem
true
link
nmyc
type
ifn
transcript
respons
infect
poli
c
treatment
supplementari
figur
though
studi
cell
system
nb
cell
line
suggest
link
nmyc
observ
effect
viru
suscept
establish
ifninduc
antivir
state
link
may
true
nb
cell
popul
studi
frequenc
link
cell
variou
clinic
specimen
would
help
determin
util
nmyc
biomark
virotherapi
respons
microarray
data
consist
sever
hit
classifi
isg
nonisg
nonisg
consist
gene
found
interferom
due
high
number
identifi
isg
microarray
data
known
antivir
function
gene
differenti
establish
antivir
state
exogen
poli
c
decid
focu
analysi
gene
howev
observ
differ
viru
replic
virusinduc
cell
kill
also
attribut
nonisg
variou
cellular
function
eg
cell
cycl
progress
activationregul
signal
pathway
enzymat
apoptot
function
etc
current
investig
role
nonisg
viru
replic
summari
show
nmycamplifi
cell
cell
induc
overexpress
nmyc
suscept
virusinduc
cell
kill
fail
establish
robust
antivir
state
type
ifn
high
nmyc
level
correl
increas
suscept
virusinduc
cell
kill
chang
global
gene
express
data
suggest
nmycdriven
downregul
isg
antivir
function
may
mechan
promot
differenti
virusinduc
cell
kill
studi
suggest
nmyc
amplif
hallmark
highrisk
neuroblastoma
potenti
biomark
respons
virotherapi
efficaci
highrisk
diseas
nonnmyc
amplif
may
suboptim
therefor
oncolyt
virotherapi
highrisk
nb
nmyc
amplif
would
probabl
requir
sensit
tumor
chemo
drug
prior
infect
develop
syngen
model
isogen
cell
line
express
low
high
nmyc
level
would
provid
insight
function
relationship
tumor
stroma
may
determin
virotherapi
efficaci
vivo
neuroblastoma
cell
line
sknsh
skna
shep
control
cell
maintain
dmem
tissu
cultur
medium
life
technolog
grand
island
ny
supplement
fb
life
technolog
lglutamin
life
technolog
humidifi
incub
doxycyclin
ad
cultur
medium
cell
cell
provid
dr
manfr
schwab
deutch
krebsforschungszentrum
divis
tumor
genet
cultur
routin
test
mycoplasma
contamin
genet
modifi
vsv
strain
deriv
indiana
serotyp
propag
bhk
cell
mutant
viru
delet
methionin
protein
insert
extra
cistron
encod
green
fluoresc
protein
gfp
g
l
cell
infect
indic
multipl
infect
moi
cell
cultur
supernat
collect
variou
time
point
viru
titrat
bhk
cell
viru
growth
curv
one
multistep
alamar
blue
assay
invitrogen
frederik
md
carri
studi
viru
replic
spread
cell
viabil
respect
cell
line
deriv
shep
harbor
repress
control
system
regul
express
exogen
nmyc
nmyc
overexpress
induc
doxycyclin
withdraw
cultur
medium
hour
control
cell
harbor
repress
system
except
exogen
nmyc
gene
present
nmyc
express
assess
rtpcr
western
blot
cell
treat
doxycyclin
infect
moi
hpi
treat
intracellular
extracellular
polyinosinicpolycytidyl
acid
poli
c
st
loui
mo
ngwell
plate
format
respect
hour
transfect
poli
c
ngwell
toxic
effect
low
nmyc
cell
cultur
supernat
harvest
puls
remov
cell
debri
store
readi
use
detect
quantit
secret
carri
use
verikin
human
interferon
beta
kit
r
system
minneapoli
mn
accord
manufactur
instruct
transcript
analysi
rna
extract
qiagen
follow
rtpcr
degener
primer
use
detect
specif
primer
detect
forward
revers
gtctcattccagccagtgct
nmyc
forward
revers
control
assay
cell
treat
either
intracellular
transfect
extracellular
poli
c
reduc
serum
medium
life
technolog
concentr
intracellular
extracellular
poli
c
optim
cell
except
skna
nb
cell
treat
extracellular
poli
c
skna
treat
extracellular
poli
c
toxic
beyond
concentr
poli
c
transfect
perform
sixwel
plate
format
nmycamplifi
cell
transfect
poli
c
use
lipofectamin
invitrogen
carlsbad
ca
nonnmycamplifi
cell
transfect
poli
c
higher
amount
toxic
effect
cell
cell
incub
extracellular
reduc
serum
medium
intracellular
poli
c
sixwel
plate
format
hour
transfect
beyond
poli
c
toxic
effect
low
nmyc
monitor
transfect
effici
cell
transfect
variou
amount
pll
carri
gfp
gene
addgen
cambridg
analysi
jakstat
signal
nmyc
detect
cell
either
treat
doxycyclin
seed
cell
per
well
sixwel
plate
incub
cell
either
infect
wash
icecold
pb
collect
scrape
lyse
lysi
buffer
mmoll
tri
ph
mmoll
nacl
glycerol
leupeptin
aprotinin
sodium
orthovanad
minut
follow
sonic
three
time
puls
amplitud
centrifug
protein
prepar
quantifi
bca
protein
assay
biolynx
brockvil
canada
run
polyacrilmyd
gel
transfer
onto
nitrocellulos
membran
membran
incub
monoclon
antibodi
nmyc
emd
millipor
darmstadt
germani
stat
abcam
cambridg
actin
emd
millipor
rigi
novou
biolog
littleton
co
polyclon
antibodi
abcam
goat
antimous
rabbit
igghrp
santa
cruz
biotechnolog
dalla
tx
use
secondari
antibodi
cell
treat
doxycyclin
seed
plate
cellswel
hour
follow
pretreat
uml
exogen
human
pbl
interferon
sourc
piscataway
nj
hour
cell
infect
moi
viabil
determin
alamar
blue
assay
invitrogen
frederik
md
accord
manufactur
instruct
experi
done
triplic
phasecontrast
fluoresc
imag
cell
taken
use
carl
zeiss
invert
microscop
axiovert
mount
carl
zeiss
digit
camera
axiocam
mrc
lake
success
ny
treat
doxycyclin
cultur
cm
dish
incub
hour
cell
cultur
supernat
remov
replac
poli
c
reduc
serum
media
life
technolog
cell
incub
anoth
hour
supernat
remov
cell
wash
four
time
serumfre
medium
dmem
life
technolog
elimin
remain
poli
c
fresh
serumfre
dmem
ad
onto
cell
follow
incub
anoth
hour
supernat
harvest
centrifug
either
four
time
concentr
fb
ad
final
concentr
supernat
use
condit
media
protect
assay
skna
cultur
condit
media
regular
dmem
medium
fb
overnight
follow
infect
moi
hour
viabil
assay
alamar
blue
life
technolog
use
condit
media
virusinfect
cell
hpi
moi
uvirradi
minut
inactiv
viru
uvirradi
condit
media
test
cell
monitor
viru
inactiv
microarray
assay
use
affymetrix
genechip
human
prime
view
carri
cell
either
treat
doxycyclin
infect
moi
hour
time
around
cell
express
gfp
encod
rna
extract
rneasi
plu
mini
kit
qiagen
assess
rna
qualiti
rna
integr
number
rin
measur
agil
rna
nanochip
bioanalyz
agil
technolog
santa
clara
ca
quantiti
measur
use
nanodrop
nanodrop
technolog
wilmington
de
total
ng
rna
sampl
rin
higher
label
ivt
express
kit
ambion
hybrid
affymetrix
genechip
human
primeview
array
hour
array
stain
wash
use
affymetrix
genechip
follow
manufactur
protocol
scan
use
affymetrix
genechip
scanner
system
data
analysi
affymetrix
genechip
array
data
file
gener
use
genechip
command
consol
softwar
agcc
statist
analysi
carri
use
partek
genom
suit
partek
incorpor
analysi
varianc
p
appli
statist
signific
fold
chang
p
includ
analysi
isg
identifi
use
interferon
databas
cell
infect
moi
hour
control
cell
treat
tunicamycin
hour
cell
harvest
rna
protein
extract
analyz
express
transcript
semiquantit
rtpcr
protein
level
respect
rtpcr
carri
forward
ttgcctttctcttcggacact
revers
gctagctgtgccactttcc
specif
primer
mous
monoclon
antibodi
abcam
use
western
blot
